Comparison of the novel Franseen needle versus the fine-needle aspiration needle in endoscopic ultrasound-guided tissue acquisition for cancer gene panel testing: A propensity score-matching analysis.
endoscopic ultrasound‐guided fine‐needle aspiration
endoscopy
fine‐needle biopsy
neoplasms
oncogenes
Journal
JGH open : an open access journal of gastroenterology and hepatology
ISSN: 2397-9070
Titre abrégé: JGH Open
Pays: Australia
ID NLM: 101730833
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
20
06
2023
revised:
22
08
2023
accepted:
24
08
2023
medline:
25
9
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
epublish
Résumé
Reports have indicated that a surface area of 4 mm From April 2010 to December 2021, among 693 EUS-TA cases, EZ3 was used in 390 cases and TopGain in 45. The EZ3 and TopGain groups were matched in a 1:1 ratio with a tolerance of 0.2, with 35 patients each matched using propensity score analysis. The TopGain group had a significantly higher percentage of cases with a tissue area of ≥4 mm EUS-TA using TopGain significantly collected more ≥4 mm
Sections du résumé
Background and Aim
UNASSIGNED
Reports have indicated that a surface area of 4 mm
Method
UNASSIGNED
From April 2010 to December 2021, among 693 EUS-TA cases, EZ3 was used in 390 cases and TopGain in 45. The EZ3 and TopGain groups were matched in a 1:1 ratio with a tolerance of 0.2, with 35 patients each matched using propensity score analysis.
Results
UNASSIGNED
The TopGain group had a significantly higher percentage of cases with a tissue area of ≥4 mm
Conclusions
UNASSIGNED
EUS-TA using TopGain significantly collected more ≥4 mm
Identifiants
pubmed: 37744704
doi: 10.1002/jgh3.12965
pii: JGH312965
pmc: PMC10517436
doi:
Types de publication
Journal Article
Langues
eng
Pagination
652-658Informations de copyright
© 2023 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Cancer Sci. 2019 Apr;110(4):1480-1490
pubmed: 30742731
Cancer Cytopathol. 2013 Dec;121(12):688-94
pubmed: 23893923
J Gastroenterol. 2022 Dec;57(12):990-998
pubmed: 36190682
Dig Endosc. 2023 Jan;35(1):124-133
pubmed: 35993898
Clin Endosc. 2023 Mar;56(2):221-228
pubmed: 36879539
Endoscopy. 2017 Oct;49(10):989-1006
pubmed: 28898917
Endosc Int Open. 2019 Aug;7(8):E955-E963
pubmed: 31367675
Endoscopy. 2021 Apr;53(4):376-382
pubmed: 32767288
Chin Clin Oncol. 2019 Apr;8(2):16
pubmed: 31070037
Can J Gastroenterol Hepatol. 2019 Feb 3;2019:8581743
pubmed: 30854353
Oncotarget. 2016 Aug 23;7(34):54526-54536
pubmed: 27203738
Cancer Cytopathol. 2022 Apr;130(4):275-283
pubmed: 34905283
Cancer Sci. 2021 Jan;112(1):296-304
pubmed: 33007138
Oncol Lett. 2016 Nov;12(5):3875-3881
pubmed: 27895743
Pancreas. 2018 Sep;47(8):990-995
pubmed: 30028448
J Gastroenterol Hepatol. 2019 May;34(5):907-913
pubmed: 30422342
J Clin Med. 2021 Aug 13;10(16):
pubmed: 34441856
Pathol Int. 2020 Dec;70(12):921-931
pubmed: 32956529
Genome Med. 2018 Jun 7;10(1):44
pubmed: 29880027
Gut. 2018 Dec;67(12):2081-2084
pubmed: 28988195
J Clin Med. 2019 Aug 05;8(8):
pubmed: 31387310
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
BMC Gastroenterol. 2021 Jan 7;21(1):21
pubmed: 33413133